Collectively, our results provide insight into how CDH11 regulates macrophage biology during pulmonary fibrosis and suggests that targeting CDH11 on macrophages could be a viable therapeutic strategy for the prevention and treatment of pulmonary fibrosis. Here, CDH11 is linked to pulmonary fibrosis.